Riedel's thyroiditis medical therapy

Riedel's thyroiditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Riedel's thyroiditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Riedel's thyroiditis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Riedel's thyroiditis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Riedel's thyroiditis medical therapy
CDC on Riedel's thyroiditis medical therapy
Riedel's thyroiditis medical therapy in the news
Blogs on Riedel's thyroiditis medical therapy
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Riedel's thyroiditis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Tamoxifen has been proposed as part of a treatment plan.

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.
• Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].
• The majority of cases of [disease name] are self-limited and require only supportive care.

• [Disease name] is a medical emergency and requires prompt treatment.

• The mainstay of treatment for [disease name] is [therapy].

 

• The optimal therapy for [malignancy name] depends on the stage at diagnosis.
• [Therapy] is recommended among all patients who develop [disease name].
• Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
• Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
• Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
• Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Medical Therapy

• Pharmacologic medical therapies for Riedel's thyroiditis include Corticosteroids and tamoxifen.

Disease Name

• Adult
  • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
  • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
    • • • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days

• Pediatric
  • Preferred regimen (1): drug name 50 mg/kg PO per day q8h (maximum, 500 mg per dose)
  • Preferred regimen (2): drug name 30 mg/kg PO per day in 2 divided doses (maximum, 500 mg per dose)